n (%) | Total patients with chronic diseases 9443 (100%) | 95% CI | Non-polypharmacy patients 7845 (83.1%) | 95% CI | Polypharmacy patients 1598 (16.9%) | 95% CI | p |
---|---|---|---|---|---|---|---|
Sociodemographic variables | |||||||
Female | 5862 (62.1%) | 61.1–63.1 | 4,761 (60.7%) | 59.6–61.8 | 1,101 (68.9%) | 66.6–71.2 | < 0.01 |
Age* | 57.6 [18.7] | 57.4–58.2 | 52.7 [16.1] | 52.4–53.1 | 82.7 [7.1] | 82.4–83.1 | < 0.01 |
≤ 75 years | 7473 (79.1%) | 78.3–80.0 | 7,318 (93.3%) | 92.7–93.8 | 155 (9.7%) | 8.3–11.2 | < 0.01 |
> 75 years | 1970 (20.9%) | 20.0–21.68 | 527 (6.7%) | 6.2–7.3 | 1,443 (90.3%) | 88.9–91.8 | |
Origin Spain | 7762 (82.2%) | 81.4–83.0 | 6,381 (81.3%) | 80.5–82.2 | 1,381 (86.4%) | 84.7–88.1 | < 0.01 |
Rest of Europe | 346 (3.7%) | 3.3–4.0 | 300 (3.8%) | 3.4–4.2 | 46 (2.9%) | 2.1–3.7 | |
Rest of the world | 1335 (14.1%) | 13.4–14.8 | 1,164 (14.8%) | 14.1–15.6 | 171 (10.7%) | 9.2–12.2 | |
Functional variables | |||||||
Immobilized | 300 (3.2%) | 2.8–3.5 | 43 (0.5%) | 0.4–0.7 | 257 (16.1%) | 14.3–17.9 | < 0.01 |
Institutionalized | 161 (1.7%) | 1.4–2.0 | 45 (0.6%) | 0.4–0.7 | 116 (7.3%) | 6.0–8.5 | < 0.01 |
Primary caregiver | 228 (2.4%) | 2.1–2.7 | 28 (0.4%) | 0.1–0.5 | 200 (12.5%) | 10.9–14.1 | < 0.01 |
Home support | 80 (0.8%) | 0.7–1.0 | 9 (0.1%) | 0.04–0.2 | 71 (4.4%) | 3.4–5.5 | < 0.01 |
Palliative care | 44 (0.5%) | 0.3–0.6 | 14 (0.2%) | 0.09–0.3 | 30 (1.9%) | 1.2–2.5 | < 0.01 |
Clinical variables | |||||||
AMG Risk Level High | 443 (4.7%) | 4.3–5.1 | 92 (1.2%) | 0.9–1.4 | 351 (22.0%) | 19.9–24.0 | < 0.01 |
Medium | 1770 (18.7%) | 18.0–19.5 | 996 (12.7%) | 12.0–13.4 | 774 (48.4%) | 46.0–50.9 | |
Low | 7230 (76.6%) | 75.7–77.4 | 6,757 (86.1%) | 85.4–86.9 | 473 (29.6%) | 27.3–31.8 | |
Complexity index* | 6.9 [7.1] | 6.7–7.0 | 5.2 [4.5] | 5.1–5.3 | 15.1 [10.9] | 14.6–15.6 | < 0.01 |
Chronic diseases* | 2.6 [1.8] | 2.56–2.63 | 2.2 [1.4] | 2.1–2.2 | 4.8 [2.2] | 4.64–4.86 | < 0.01 |
Multimorbidity | 5991 (63.4%) | 62.5–64.4 | 4,463 (56.9%) | 55.8–58.0 | 1,528 (95.6%) | 94.6–96.6 | < 0.01 |